Skip to content
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
Recent Press
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
Recent Press
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
Recent Press
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
Recent Press
VIC NEWS
NEWS HIGHLIGHTS
From the blog
Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity
January 17, 2023
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
January 4, 2023
Keystone Symposium selects Dr. Alagpulinsa for 2023 Fellows Program
December 12, 2022
Novel HIV vaccine approach shows promise in first-in-human clinical trial
December 12, 2022
Dr. Poznansky Gives an Invited Research Talk about Latest Advances at VIC
November 16, 2022
Investigating Cancer Immunotherapy Effects on COVID-19 Outcomes
November 16, 2022
New approaches to needle-less vaccine delivery
November 4, 2022
A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma
November 4, 2022
Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds
October 24, 2022
VIC lab members enjoying social gatherings this summer.
September 8, 2022
Undergraduates enjoy a successful summer internship at VIC!
September 7, 2022
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes.
September 7, 2022
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetti Immunity.
September 7, 2022
2022 WMIF | The Dr. Is In | Leveraging Novel Mechanisms for Vaccine and Immunotherapy Development
July 6, 2022
David Verrill Goodbye Event
June 2, 2022
EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever
June 2, 2022
COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic
May 12, 2022
A new platform for immunotherapeutic RNA delivery to cancer cells
May 2, 2022
Immune cell ‘Soldier’ identified as potential target for immunotherapy
May 2, 2022
Dual-drug treatment offers promise for advanced melanoma patients
April 12, 2022
Novel drug combination may boost chemoimmunotherapy response in bladder cancer patients
April 5, 2022
Two-pronged immunotherapy treatment tested for effectiveness against glioblastomas
April 5, 2022
Recent data published indicates great hope in a newly developed COVID-19 vaccine
March 21, 2022
Restoring p53 function with mRNA nanoparticles and immune checkpoint blockade to enhance immunotherapy
March 14, 2022
181 Nobel Laureates condemn Vladimir Putin’s unprovoked and brutal invasion of Ukraine.
March 14, 2022
Exciting research reveals new potential in investigating “hybrid immunity” against Covid-19 and evolving variant
March 2, 2022
Three pillars of pandemic preparedness to end this one while preparing for the next
February 14, 2022
Voltron Therapeutics, a Laidlaw Venture Partner, Announces Selection of Therapeutic Targets for Immuno-Oncology Program
January 31, 2022
B cells do more than just help fight infection: a new study shows that they can support tissue repair and regeneration after injury
January 31, 2022
FASEB Journal publication from VIC’s Dr. Sîrbulescu and her team.
November 22, 2021
Mark Poznansky and VIC hosted the annual Professor Dulcie V. Coleman Lecture
November 22, 2021
Clofazimine for babesiosis: preclinical data support a clinical trial
October 21, 2021
IBD Patients Like Eric Prompt More Questions About COVID-19
September 18, 2021
A Virus-Hunter’s Advice on Dealing with China’s Resistance on Covid
September 18, 2021
« Prev
1
2
3
Next »
VICatMGH
Philanthropic support is critical to VIC’s success
DONATE
>
